TEVOGEN BIO

Dr. Neal Flomenberg, Chief Scientific Officer, discussed TEVOGEN BIO's goal of making cytotoxic #Tcell #immunotherapy a #mainstream, outpatient treatment, which he felt was achievable if the therapy was safe, affordable, readily - rapidly accessible, and comfortable for patients. $TVGN #affordable #accessible #celltherapy #oncology #neurology #virology #biotech

TEVOGEN BIO Founder and CEO Ryan Saadi, MD, MPH sat down with Deborah Balshem of Mergermarket to discuss the company's partnership and capital options. Distributed with permission from Deborah Balshem. #TVGN #affordable #accessible #celltherapy #oncology #neurology #virology #biotech Fundamental Research Corp. Zito Partners

Link ➡ https://lnkd.in/gDJnjJw2 “We remain committed to transparency and open communication with our stockholders. We believe that our ongoing efforts and strategic initiatives will position Tevogen Bio for sustained growth and success. Thank you for your continued trust and support,” - Ryan Saadi, MD, MPH Founder and CEO TEVOGEN BIO #TVGN #affordable #accessible #celltherapy #oncology #neurology #virology #biotech

Neal Flomenberg, Chief Scientific Officer, and Dolores Grosso, Clinical Development Lead, sit down with Nasdaq's Kristina Ayanian to discuss how TEVOGEN BIO is harnessing CD8+ cytotoxic T lymphocytes to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. #TVGN #affordable #accessible #celltherapy #oncology #neurology #virology #biotech

https://lnkd.in/gNh6Qs-P Ryan Saadi, MD, MPH Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility #TVGN #affordable #accessible #celltherapy #biotech

TEVOGEN BIO providing new hope for COVID patients https://lnkd.in/gfQdksgw Thank you NJBIZ for the wonderful coverage! #TVGN #affordable #accessible #celltherapy #biotech #Covid19

🎆 Happy Fourth of July from Team TEVOGEN BIO! 🎇 Wishing everyone a memorable day filled with celebration and gratitude. #FourthOfJuly #IndependenceDay

#TVGN #ANALYST REPORT Fast Tracking a Potential Breakthrough for Treating Viral Infections and Cancer https://lnkd.in/gVa2H8VC #affordable #accessible #celltherapy #biotech

“We are excited by the outcomes of the phase I trial and are looking forward to both confirming the safety of TVGN 489 and further testing their efficacy in later stage trials in elderly and immune compromised patients with COVID-19 who continue to have higher risk outcomes,” said Dolores Grosso, DNP, TEVOGEN BIO's Global Clinical Development Lead #affordable #accessible #celltherapy #biotech #COVID19 #ClinicalTrial #TVGN American Society of Hematology

Mittul Mehta, TEVOGEN BIO's Chief Information Officer and Head of Tevogen.AI, at the Longwood Healthcare Leaders Spring MIT Conference. Mehta emphasized the transformative potential of Tevogen Bio’s innovative T cell technology and the company’s groundbreaking approach to overcoming industry challenges. #affordable #sustainable #healthequality #celltherapy #biotech #AI #TVGN #longwoodhealthcareleaders